GSDMD and cancer: They identified a specific small molecule agonist of GSDMD, quinoxaline 6,7-dichloro-2-methylsulfonyl-3-N-tert-butylaminoquinoxaline (DMB), which can directly activate GSDMD-mediated cancer cell pyroptosis.